Biography

1. Research Interest

(1) Basic and clinical study on chronic liver disease

(2) Non-biological artificial liver treatment for patients with liver failure

(3) Non-surgical treatment for patients with liver cancer

2. Educational Background

(1)1984.09-1989.08Bachelor's Degree

Department of Medicine, Tianjin Medical College

(2)1992.09-1995.07Master's Degree

Tianjin Medical University

(3)2000.09-2000.12 Visiting Scholar

King's College Hospital,UK

(4)2007.09-2010.06Doctor’s Degree

Tianjin Medical University

3. Work Experience

(1)1989.08-1992.09Resident Doctor

Tianjin Third Central Hospital

(2)1995.09-1998.12Vice president  

Tianjin Third Central Hospital

(3)2000.12-2004.07Vice president, Associate chief physician

Tianjin Third Central Hospital

(4)2004.07-2009.02President, Chief physician

Tianjin Haihe Hospital

(5)2009.02-presentPresident, Institute director, Chief physician

Tianjin Second People’s Hospital

Tianjin Institute of Hepatology

(6)2014.06-presentParty Committee Secretary, Vice president

Tianjin First Central Hospital

4. Awards

(1) 2012Non-bioartificial liver

(2) 2013 Clinical study on quantitative removal of neonatal HBsAg by HBIG

(3) 2014Clinical and pathological characteristics and antiviral efficacy of chronic hepatitis B complicated with fatty liver

(4) 2015 Diagnostic value of Fibroscan combined with Fibrotest in liver Fibrosis in patients with chronic Hepatitis B

(5) 2016 Study on risk factors and pathogenesis of gastric mucosal injury induced by non-steroidal anti-inflammatory drug (NSAID)

5. Social Service

(1) Standing member of committee of the Chinese Society of Gastroenterology

(2) Member of digestive branch of the Chinese Medical Doctor Association

(3) Deputy leader of hepatobiliary cooperation group of digestive branch of Chinese Medical Association

(4) Chairman of the gastroenterology branch of Tianjin Medical Association

(5) Editor of Gastroenterology (Chinese version), Chinese Journal of Digestion……

Achievements

Peer-Reviewed Journal Papers

[1]Yang X, Li J, Liu J, Gao M, Zhou L, Lu W*. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment A longitudinal observational study [J].Medicine, 2017, 96 (23):e7064. （Corresponding author）

[2]Xu L，Lu W*，Li P，F Shen，et al. A comparison of hepatic steatosis index,controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B [J]. Dig Liver Dis, 2017:910-917.（Corresponding author）

[3]Ma P, Gao L, Zhang D, Yu A1, Qiu C, Li L, Yu F, Wu Y, You W, Guo Y, Ning X, Lu W*. Trends in the incidence of AIDS and epidemiological features in Tianjin, China from 2005 to 2016[J]. Oncotarget, 2017, 8(60):102540-102549.（Corresponding author）

[4]Jia JD, Xie W, Ding HG, Mao H, Guo H, Li Y, Wang X, Wang JF, Lu W*, et al. Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: A prospective cohort study[J]. Ann Hepatol, 2017, 16(1):123-132.（Corresponding author）

[5]Su R, Rao Y, Shen X, Zhu J, Ji A, Jin G, Dai C, Hou W, Yu M, Lu W*. Preparation and Adsorption Properties of Novel Porous Microspheres with Different Concentrations of Bilirubin [J]. Blood Purification, 2016, 42(2):104.（Corresponding author）

[6]Zhang NN，Lu W*，Cheng XJ，Liu JY，Zhou YH，et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence [J]. Clinical Radiology, 2015, 70(11):1237-1243.（Corresponding author）

[7]Jing Q, Jianyong L, Jiming Y, Shuren L, Rui W, Lu W*. Predictive value of recurrence for serum hypoxia inducible factor 1 α C reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization [J]. Indian Journal of Cancer, 2015, 52 Suppl2(6):e105.（Corresponding author）

[8]Mi YQ, Shi QY, Xu L, Shi RF, Liu YG, Li P, Shen F, Lu W*, Fan JG. Controlled Attenuation Parameter for Noninvasive Assessmentof Hepatic Steatosis Using Fibroscan: Validation in ChronicHepatitis B [J]. Digestive Diseases & Sciences, 2015, 60(1):243-251.（Corresponding author）

[9]Zhang NN，Lu W*，Cheng XJ，Liu JY，Zhou YH，et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence [J]. Clinical Radiology, 2015, 70(11):1237-1243.（Corresponding author）

[10]Ma P, Yang JM, Hou W, Song SD, Wang L, Lu W*. A preliminary study on the efficacy dan influencing factors of interferon for the treatment of genotype 1 chronic C with different dosage forms [J]. Eur J Gastroenterol Hepatol, 2013, 25(5):601-605.（Corresponding author）

[11]Wang CY, Wen J, Zhou YH, Li S, Zhang Y, Lu W*, Li J. Predictive value for esophageal varices using acoustic radiation force impulse elastography in post-hepatitis B cirrhosis patients [J]. Chinese Journal of Hepatology 2018;26(7):499-502.（Corresponding author）

[12]Wang CY, Hu DS, Wen J, Lu W*, Li J.Upper gastrointestinal bleeding caused by exfoliative esophagitis in one patient with hepatitis B cirrhosis [J]. Chinese Journal of Hepatology 2017;25(11):868-869.（Corresponding author）

[13]Lu W. Review of important academic progress in digestion in 2016. China Medical News 2017,32(3):11-12

[14]Lu W, Li S. Endoscopic ultrasonography: a new method for evaluation, diagnosis, and treatment of portal hypertension. Chinese Journal of Hepatology2017,25(6):411-414

[15]Cui YF, Lu W*, Gao W, Dong C, Han C, Liu YH. Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver. Chinese Critical Care Medicine 2017,29(10):926-930. (Corresponding author)

[16]Rao Y, Lu W*, Zhang NN, Wang CY, Zhou L, Li J, Su R. An observation on curative effect of high-powered microwave ablation combined with trans-hepatoarterial chemoembolization for treatment of larger hepatocellular carcinoma. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2016, 23(2): 186-190. (Corresponding author)

[17]Wang CY, Jiang B, Li J, Li S, Hu DS, Wei J, Guo XL, Lu W*. Value of endoscopic ultrasound in early diagnosis of gastroesophageal varices in patients with liver cirrhosis [J]. Chinese Journal of Hepatology 2016;24(9):671-675.（Corresponding author）

[18]Jiang B, Dai CY, Li XM, Su R, Xu J, Cao Y, Hou W, Lu W*. Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology [J]. Chinese Journal of Hepatology 2016;24(1):36-39.（Corresponding author）

[19]Lu W, Zhang N. Perspectives on the multidisciplinary treatment approach for hepatocellular carcinoma [J]. Chinese Journal of Hepatology 2015;23(10):730-732.

Projects

1.Efficacy of tenofovir in the treatment of decompensated posthepatitic liver cirrhosis and its effect on Th17/Treg balance

Time：2017.9-2020.6

2.Tianjin Clinical Medical Research Center for Organ Transplantation

Time：2016.4-2019.3

3.Mechanism of inhibition of hepatic stellate cell activation by EGB-NK against hepatic fibrosis

Time：2016.1-2019.1